For research use only. Not for therapeutic Use.
AR-Brivaracetam(CAT: C000076) is a pharmaceutical compound. Its mode of action involves binding to synaptic vesicle protein 2A (SV2A), thereby modulating neurotransmitter release and reducing excessive neuronal excitability. In the field of pharmaceuticals, AR-Brivaracetam is primarily used as an antiepileptic drug, effective in managing various types of seizures, including partial-onset seizures in adults with epilepsy.
Catalog Number | C000076 |
CAS Number | 357337-00-9 |
Synonyms | 5-(4-Morpholinylmethyl-d2)-3-[[(5-nitro-2-furanyl)methylene]amino]-2-oxazolidinone-4,4,5-d3; |
Molecular Formula | C₁₁H₂₀N₂O₂ |
Purity | ≥95% |
Solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
Appearance | White to Pale Yellow Solid |
Storage | 4°C |
Reference | Differding, E., et al.: PCT Int. Appl. (2001), WO 2001062726 A2 20010830; Rosenstiel, P., et al.:Neurotherapeutics, 4 (1), 84 (2007); Malawska, B., et al.:, Curr. Opin. Investig. Drugs, 6(7), 740 (2005); |